ACR Meeting Abstracts
Abstract Number: 714 • ACR/ARHP Annual Meeting 2015
Matthew A. Brown1, Paul A. Bird2, Philip C. Robinson3, Philip J. Mease4, Filip van Den Bosch5, Christine Surian6, Zirke Wiid6, Heather Jones7, Annette Szumski8 and Lisa Marshall7, 1Translational Research Institute, University of Queensland Diamantina Institute, Brisbane, Australia, 2University of New South Wales, Sydney, Australia, 3University of Queensland & Royal Brisbane and Women's Hospital, Brisbane, Australia, 4Rheumatology Research, Swedish Medical Center, Seattle, WA, 5Department of Rheumatology, Ghent University Hospital, Ghent, Belgium, 6Pfizer Australia, Sydney, Australia, 7Inflammation Global Medical Affairs, Pfizer, Collegeville, PA, 8Department of Biostatistics, Pfizer, Collegeville, PA
Background/Purpose: Treatment with tumor necrosis factor α (TNFα) inhibitors has been shown to be effective in improving disease activity and functional capacity in patients with…